GSK Investigational Site

Windsor 5000

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Ovarian Neoplasms, Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma

Studies at this site

• A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer — Running, not enrolling
• A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed